565 related articles for article (PubMed ID: 28183334)
1. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
2. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.
Mattoo H; Mahajan VS; Della-Torre E; Sekigami Y; Carruthers M; Wallace ZS; Deshpande V; Stone JH; Pillai S
J Allergy Clin Immunol; 2014 Sep; 134(3):679-87. PubMed ID: 24815737
[TBL] [Abstract][Full Text] [Related]
3. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
5. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.
Wallace ZS; Mattoo H; Carruthers M; Mahajan VS; Della Torre E; Lee H; Kulikova M; Deshpande V; Pillai S; Stone JH
Ann Rheum Dis; 2015 Jan; 74(1):190-5. PubMed ID: 24817416
[TBL] [Abstract][Full Text] [Related]
6. Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.
Wang X; Jiang Y; Zhu Y; Zhang M; Li M; Wang H; Gao P
J Cell Mol Med; 2016 May; 20(5):804-14. PubMed ID: 26800315
[TBL] [Abstract][Full Text] [Related]
7. Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease.
Akiyama M; Suzuki K; Yamaoka K; Yasuoka H; Takeshita M; Kaneko Y; Kondo H; Kassai Y; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
Arthritis Rheumatol; 2015 Sep; 67(9):2476-81. PubMed ID: 25989153
[TBL] [Abstract][Full Text] [Related]
8. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation.
Mao H; Pan F; Wu Z; Wang Z; Zhou Y; Zhang P; Gou M; Dai G
Int Immunopharmacol; 2017 Aug; 49():95-101. PubMed ID: 28558303
[TBL] [Abstract][Full Text] [Related]
9. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease.
Akiyama M; Yasuoka H; Yamaoka K; Suzuki K; Kaneko Y; Kondo H; Kassai Y; Koga K; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 Jul; 18():167. PubMed ID: 27411315
[TBL] [Abstract][Full Text] [Related]
10. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.
Wallace ZS; Deshpande V; Mattoo H; Mahajan VS; Kulikova M; Pillai S; Stone JH
Arthritis Rheumatol; 2015 Sep; 67(9):2466-75. PubMed ID: 25988916
[TBL] [Abstract][Full Text] [Related]
11. Expansion of blood IgG
Heeringa JJ; Karim AF; van Laar JAM; Verdijk RM; Paridaens D; van Hagen PM; van Zelm MC
J Allergy Clin Immunol; 2018 May; 141(5):1831-1843.e10. PubMed ID: 28830675
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease.
Chen Y; Lin W; Yang H; Wang M; Zhang P; Feng R; Chen H; Peng L; Zhang X; Zhao Y; Zeng X; Zhang F; Zhang W; Lipsky PE
Arthritis Rheumatol; 2018 Nov; 70(11):1853-1865. PubMed ID: 29781221
[TBL] [Abstract][Full Text] [Related]
13. Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
Pozdzik A; Beukinga I; Gu-Trantien C; Willard-Gallo K; Nortier J; Pradier O
Mediators Inflamm; 2016; 2016():7651024. PubMed ID: 27493452
[TBL] [Abstract][Full Text] [Related]
14. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):159-166. PubMed ID: 30652677
[TBL] [Abstract][Full Text] [Related]
15. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
[TBL] [Abstract][Full Text] [Related]
16. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
18. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
[TBL] [Abstract][Full Text] [Related]
19. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
20. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease.
Kubo S; Nakayamada S; Zhao J; Yoshikawa M; Miyazaki Y; Nawata A; Hirata S; Nakano K; Saito K; Tanaka Y
Rheumatology (Oxford); 2018 Mar; 57(3):514-524. PubMed ID: 29253269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
